WOW.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Cencora - Wikipedia

    en.wikipedia.org/wiki/Cencora

    Financials as of September 30, 2023. [update] [1] Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2]

  3. Steven H. Collis - Wikipedia

    en.wikipedia.org/wiki/Steven_H._Collis

    1961 or 1962 (age 62–63) [1] South Africa. Title. Chairman, president and CEO, AmerisourceBergen. Predecessor. R. David Yost. Successor. incumbent. Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen.

  4. Need help? Call us! 800-290-4726 Login / Join. Mail

  5. AmerisourceBergen (ABC) Hits 52-Week High: What's Aiding It?

    www.aol.com/news/amerisourcebergen-abc-hits-52...

    For premium support please call: 800-290-4726 more ways to reach us

  6. AmerisourceBergen (ABC) Beats on Q4 Earnings, Issues ... - AOL

    www.aol.com/news/amerisourcebergen-abc-beats-q4...

    AmerisourceBergen (ABC) registers strong growth in the Pharmaceutical Distribution segment and the World Courier business in Q4. AmerisourceBergen (ABC) Beats on Q4 Earnings, Issues '19 View Skip ...

  7. AmerisourceBergen (ABC) to Post Q3 Earnings: What's in Store?

    www.aol.com/news/amerisourcebergen-abc-post-q3...

    AmerisourceBergen's (ABC) fiscal third-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.

  8. AmerisourceBergen (ABC) Hits Fresh High: Is There Still Room ...

    www.aol.com/news/amerisourcebergen-abc-hits...

    For premium support please call: 800-290-4726 more ways to reach us

  9. AmerisourceBergen (ABC) Tops Q2 Earnings and Revenue ... - AOL

    www.aol.com/news/amerisourcebergen-abc-tops-q2...

    AmerisourceBergen (ABC) delivered earnings and revenue surprises of 5.26% and 3.23%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?